Find uplifting stories about heroes, innovations, and solutions
2593 results for "psychedelic therapy"
President Trump signed an executive order to speed up research and potential FDA approval of psychedelic therapies for veterans suffering from PTSD, depression, and addiction. While the move brings hope to those who've exhausted traditional treatments, experts emphasize these therapies still need rigorous testing in controlled settings.
President Trump signed an executive order to speed FDA review of psychedelic treatments showing 80-90% reduction in PTSD symptoms among veterans. The breakthrough therapy could help over 6,000 veterans who die by suicide each year.
A breakthrough treatment using psilocybin-assisted therapy is nearing FDA approval, offering hope to millions with treatment-resistant depression and PTSD. After decades without new psychiatric treatments, this could revolutionize how we heal mental illness.
President Trump signed an executive order directing the FDA to expedite review of psychedelic drugs showing promise for veterans suffering from PTSD, depression, and traumatic brain injuries. One treatment already shows an 80-90% reduction in symptoms within one month.
A sweeping executive order is accelerating psychedelic research for mental health treatment, unlocking funding and pathways that researchers have sought for years. The question now: Can scientists deliver on the promise fast enough to help those in crisis?
A new AI platform called Lucy is solving a critical shortage in psychedelic therapy by training facilitators using real-world data from thousands of support calls. Built from a database of actual psychedelic experiences, Lucy helps prepare therapists for the emotional challenges of guiding patients through breakthrough mental health treatments.
New research shows psychedelics like psilocybin and MDMA could help people with PTSD recover in hours instead of months by actually rewiring trauma-affected brain systems. Clinical trials reveal 67% of patients no longer met PTSD criteria after MDMA-assisted therapy, offering hope to 12 million Americans struggling with the condition.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
The Department of Veterans Affairs is testing MDMA-assisted therapy to treat veterans struggling with both PTSD and alcohol addiction, marking a new chapter in mental health care. This trial joins 19 other VA studies exploring how psychedelic treatments could help those traditional methods haven't reached.
A single dose of LSD therapy reduced depression symptoms significantly more than placebo in a late-stage clinical trial. The breakthrough brings psychedelic medicine closer to FDA approval for treating major depression.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
A therapist noticed runners open up more easily while moving, sparking a growing trend in outdoor therapy sessions. Walk-and-talk therapy combines mental health support with the proven benefits of nature and exercise.
President Trump signed an executive order to expand access to psychedelic therapies for conditions like PTSD, depression, and addiction. The move signals growing mainstream acceptance of treatments once considered fringe medicine.
A new executive order accelerates research into psychedelic medicines for mental illness, prioritizing veterans facing treatment-resistant PTSD and depression. The move ends decades of federal prohibition and could offer hope to the 17 veterans who die by suicide every day.
Researchers engineered a single tobacco plant to produce five therapeutic psychedelic compounds, creating a sustainable alternative to harvesting endangered toads and mushrooms. This biological factory could revolutionize mental health treatment access.
Massachusetts General Hospital just launched a clinical trial to find out if adding a human "coach" during ketamine therapy makes the treatment work better for depression. The study could reshape how millions access mental health care.
Over 60% of U.S. voters now strongly support making psychedelics easier to study for medical use, a 14-point jump from 2023. The shift reflects growing public curiosity about therapeutic benefits of substances like psilocybin and MDMA.
A groundbreaking depression treatment using LSD exceeded all expectations in late-stage trials, outperforming every currently approved therapy. The results could mean hope for millions who haven't found relief with existing medications.
A groundbreaking trial shows military veterans experiencing dramatic improvements in PTSD symptoms after just one session with ibogaine, a powerful natural psychedelic. The research could open new doors for millions struggling with treatment-resistant trauma.
Showing 20 of 2593